| abstract |
Provided herein are methods for identifying risk of breast cancer in a subje ct and/or a subject at risk of breast cancer, reagents and kits for carrying ou t the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome. |